Epinephrine Injector

The Defense Logistics Agency Troop Support Medical is soliciting offers for a national requirements contract for Epinephrine 0.3 MG/0.3 ML Injection, Auto-Injector 2S in 2-count boxes, with proposals due November 30, 2026 at 3:00 PM ET under Solicitation SPE2D2-26-R-0009. The acquisition is unrestricted, with no set-aside, and all sources may submit proposals. Purchases flow through the DLA and VA Pharmaceutical Prime Vendor programs, and the contractor must establish business-to-business agreements with each PPV contractor.

The contract is a firm-fixed-price requirements contract under FAR Part 12 commercial procedures, with a one-year base period and four one-year options for a maximum five-year term. Estimated annual demand is 473,905 boxes: 114,780 for DoD, 336,610 for VA, 22,515 for IHS, and 0 for BoP. Offerors must provide FDA-approved product under current Good Manufacturing Practices, a Letter of Certification (manufacturer) or Letter of Commitment (non-manufacturer) demonstrating uninterrupted supply, FDA compliance documentation, trade agreements country-of-origin information for end products and active pharmaceutical ingredients, an SF 1449, and past performance data for three relevant contracts from the prior three years. Within five days of award, the contractor must register products with RXNorm, First Data Bank, and Medi-Span, and must comply with barcode labeling and Drug Supply Chain Security Act requirements. Performance begins 45 calendar days after award, with prices effective 15 days later.

Pricing is per box for the base year and all option years, exclusive of federal excise tax, and must embed a 0.5 percent cost recovery fee. Quarterly sales reports are due within 60 days of each quarter end. Large business offerors must submit a subcontracting plan with small business goals. Award goes to the lowest-priced technically acceptable offeror, with technical acceptability and past performance assessed before lowest evaluated aggregate price. The source assigns no evaluation weights and states no dollar ceiling. The most recent amendment, Amendment 0002 posted November 4, 2026, extends the closing date from November 16, 2026 to November 30, 2026 at 3:00 PM and changes no other terms. Questions go to Jeremy Brown at (445) 737-5419 or jeremy.brown@dla.mil. The issuing office is at 700 Robbins Avenue, Philadelphia, PA. Classification: NAICS 325412, Pharmaceutical Preparation Manufacturing; PSC 6505, Drugs and Biologicals.